Both in Pharmaceuticals
Polaryx Therapeutics vs PDS Biotechnology
Over the past year PLYX returned −94.3% and PDSB returned +67.0%; their daily moves had a correlation of 0.01.
PLYX −94.3% PDSB +67.0%Growth of $1, one year, split-adjusted
| Metric | PLYX | PDSB |
|---|---|---|
| Price | $2.00 | $1.38 |
| Market cap | $99.7M | $100.0M |
| Today | 0.00% | +35.29% |
| 1 month | +0.5% | +337.7% |
| 6 months | −64.8% | +27.8% |
| Year to date | — | +79.3% |
| 1 year | — | +38.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.5M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 72.9% | 300.1% |
| Short % of float | 1.1% | 5.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).